Literature DB >> 15225662

Antibacterial macrolides: a drug class with a complex pharmacological profile.

Eman Abu-Gharbieh1, Valentina Vasina, Elisabetta Poluzzi, Fabrizio De Ponti.   

Abstract

Macrolides are widely used antibacterial agents. Although generally well tolerated, they have a number of important additional pharmacological effects, which can sometimes result in significant adverse reactions. This review focuses on three of these side effects: the prokinetic action associated with stimulation of motilin receptors, the proarrhythmic effect due to prolongation of the QT interval of the electrocardiogram and the potential for drug interactions due to inhibition of drug metabolising enzymes. For macrolides that have obtained marketing authorisation in Italy, United Kingdom or United States of America, we also considered whether these actions are properly reported in the approved summaries of the product characteristics and tried to provide strategies to identify patients at risk of significant side effects when macrolides are administered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225662     DOI: 10.1016/j.phrs.2004.01.008

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.

Authors:  John Broad; Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

2.  Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation.

Authors:  Ebru Başaran
Journal:  Turk J Pharm Sci       Date:  2017-08-15

3.  Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Authors:  Malene Plejdrup Hansen; Anna M Scott; Amanda McCullough; Sarah Thorning; Jeffrey K Aronson; Elaine M Beller; Paul P Glasziou; Tammy C Hoffmann; Justin Clark; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-18

4.  Lycopene Attenuates Tulathromycin and Diclofenac Sodium-Induced Cardiotoxicity in Mice.

Authors:  Mohamed M Abdel-Daim; Rasha Eltaysh; Azza Hassan; Shaker A Mousa
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

5.  Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions.

Authors:  Nina Hanke; José David Gómez-Mantilla; Naoki Ishiguro; Peter Stopfer; Valerie Nock
Journal:  Pharm Res       Date:  2021-10-18       Impact factor: 4.200

6.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.

Authors:  G J Sanger; Y Wang; A Hobson; J Broad
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Differential Effect of Three Macrolide Antibiotics on Cardiac Pathology and Electrophysiology in a Myocardial Infarction Rat Model: Influence on Sodium Nav1.5 Channel Expression.

Authors:  Noha E Farag; Mohamed K El-Kherbetawy; Hussein M Ismail; Ahmed M Abdelrady; Eman A Toraih; Walid Kamal Abdelbasset; Rehab M Lashine; Mohammed El-Dosoky; Sally Yussef Abed; Khalid M Ibraheem; Manal S Fawzy; Sawsan A Zaitone
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.